Comparative evaluation of three JAK2V617F mutation detection methods

The correlation of JAK2V617F with a proportion of chronic myeloproliferative disorders has generated numerous studies focused on the development of molecular-based assays for JAK2V617F detection. The current parallel study comparatively evaluated 3 JAK2V617F molecular detection methods. Genomic DNA...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of clinical pathology Vol. 128; no. 5; pp. 865 - 874
Main Authors FRANTZ, Christine, SEKORA, Donna M, HENLEY, Donald C, HUANG, Chih-Kang, QIULU PAN, QUIGLEY, Neil B, GORMAN, Eric, HUBBARD, Roger A, MIRZA, Imran
Format Journal Article
LanguageEnglish
Published Chicago, IL American Society of Clinical Pathologists 01.11.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The correlation of JAK2V617F with a proportion of chronic myeloproliferative disorders has generated numerous studies focused on the development of molecular-based assays for JAK2V617F detection. The current parallel study comparatively evaluated 3 JAK2V617F molecular detection methods. Genomic DNA from blood or bone marrow was assayed by 3 laboratories using allele-specific polymerase chain reaction (AS-PCR) or kit-based restriction fragment length polymorphism methods, which used polyacrylamide gel or capillary electrophoresis analysis. In addition, samples were sequenced in 2 of the laboratories. Results found 100% concordance among the 3 methods, with analytic sensitivities of 5% for both kit methods and 0.01% for AS-PCR. The kitbased assays detect JAK2V617F with equal sensitivity regardless of analysis method, and, despite greater sensitivity of AS-PCR, all 3 methods yielded 100% concordant results for this 36-sample set. Consistent with other reports, direct sequencing was insufficiently sensitive to serve as an initial diagnostic tool for JAK2V617F detection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9173
1943-7722